THE PREMISE
Bioequivalence
Same molecule, same Health Canada standard. Brand and generic are held to identical bars.
JUMP TO MODULE →OZEMPIC & GENERIC SEMAGLUTIDE · CANADA
Same molecule. Smarter economics.
Starting with Ozempic and generic semaglutide, we unpack the three forces — price, savings, and supply — that decide whether generics stay affordable in Canada.
THE PREMISE + THREE FORCES
EXECUTIVE SUMMARY · SKIM BEFORE YOU SCROLL
THE PREMISE
Same molecule, same Health Canada standard. Brand and generic are held to identical bars.
JUMP TO MODULE →FORCE 1
FORCE 2
MODULE 01 · MOLECULAR TWIN SCANNER
Watch the scan verify brand-name and generic semaglutide, field by field.
SPECIMEN A · BRAND
ACTIVE INGREDIENT
Semaglutide
✓ VERIFIED
MECHANISM OF ACTION
GLP-1 receptor agonist
✓ VERIFIED
HEALTH CANADA APPROVAL
Approved (T2D)
✓ VERIFIED
DOSING SCHEDULE
Once weekly subcutaneous
✓ VERIFIED
SPECIMEN B · GENERIC
ACTIVE INGREDIENT
Semaglutide
✓ VERIFIED
MECHANISM OF ACTION
GLP-1 receptor agonist
✓ VERIFIED
HEALTH CANADA APPROVAL
Approved (T2D)
✓ VERIFIED
DOSING SCHEDULE
Once weekly subcutaneous
✓ VERIFIED
BIOEQUIVALENCE VERDICT
✦ MATCH CONFIRMED
Same active ingredient. Same approval standard. Bioequivalent for its approved indication.
* Same molecule and bioequivalent for its approved indication. Approved indications differ — the first generic covers type 2 diabetes; Wegovy holds the weight-management approval. Talk to a provider about the right option for you.
MODULE 02 · ASTRONOMICS
Same molecule, different price. Watch the gap, the gravity, and the catch.
02A · THE COST GAP
$0
$0
BRAND LIST
OZEMPIC / WEGOVY
$280
GENERIC
SEMAGLUTIDE (CANADIAN)
$99
~35% OF BRAND LIST · ~65% CHEAPER
ILLUSTRATIVE MONTHLY COST · PUBLICLY REPORTED BANDS
02B · THE GRAVITY LADDER
SAME MOLECULE · PRICE IS WHAT MOVES
$0/mo
100% OF BRAND LIST
List price, no pressure.
MANUFACTURERS PULLING THE PRICE
COUNT: 1
02C · THE INCENTIVE LOOP
The May 2026 price match is a defensive discount, not a structural price drop. If patients don't adopt generics, this discount disappears once brand regains market share.
As injectable semaglutide goes generic, brand pivots to new patent-protected formats — Rybelsus (oral) is the current example. Format expansion resets the clock; generic adoption is what breaks the loop.
THE DISCOUNT IS TEMPORARY.
Sage · “Move the molecule, move the price — hmm, no. Move the price, we do.”
MODULE 03 · GALACTIC SUPPLY RADAR
One factory, one risk. Many factories, distributed risk — that's the real supply story behind brand vs generic.
FRAGILE
One production line for the entire market. Any disruption triggers a nationwide shortage.
RESILIENT
Multiple approved manufacturers producing to the same spec. If one stumbles, others cover.
REAL-EVENT TIMELINE
AUG 2023
Health Canada Ozempic shortage begins
FEB 2024
Shortage resolved after ~6 months
2026
Multiple generic semaglutide manufacturers active in Canada
Signal-strength blips above are illustrative. Timeline events are documented by Health Canada and reported by CBC.
MODULE 04 · SAGE'S TRANSMISSION LOG
Six recurring questions, answered by Sage — your patient guide across the generic frontier.
TRANSMISSION RECEIVED · SAGE
Same today, the price may be. Permanent, it is not. A discount, the brand offers now, to protect its place. Choose generic, and lower prices for all, you help secure.
MODULE 05 · ADJACENT ORBITS
The bioequivalence, incentive-loop, and supply logic applies across categories. ED, hair loss, and sleep are next.
Generic tadalafil and sildenafil, decoded the same way.
Finasteride's brand-vs-generic gap, illuminated.
The next orbits Sage will chart. Patience, you must have.
FINAL TRANSMISSION
Talk to a licensed Canadian provider about whether generic semaglutide is right for you. Same molecule, same standards, same care.
Explore Options with a Licensed Provider